{
  "meta": {
    "title": "Tyrosinemia_Hartnup_Disorder_Homocysteinuria_Pyqs",
    "url": "https://brainandscalpel.vercel.app/tyrosinemia-hartnup-disorder-homocysteinuria-pyqs-d9411a25.html",
    "scrapedAt": "2025-11-29T18:33:04.240Z"
  },
  "questions": [
    {
      "id": 16463,
      "choices": [
        {
          "id": 65812,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is an Autosomal Recessive disorder</span></span></span></p>"
        },
        {
          "id": 65813,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tendon reflexes in the baby is hyperreactive</span></span></span></p>"
        },
        {
          "id": 65814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decrease phenylalanine and Tyrosine in diet&nbsp; </span></span></span></p>"
        },
        {
          "id": 65815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Most of the babies are normal during birth</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 4-month-old infant presents to the pediatric department with a distinct fair complexion, blue eyes, blond hair, an eczematous rash, and a musty odor in the diapers. The mother reports concerns raised by a medical student about the child&#39;s unusual features. After evaluating the clinical presentation, the physician suspects Phenylketonuria (PKU). Which of the following statements about Phenylketonuria is incorrect?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture5_sNq2OQo.jpg\" style=\"height:319px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q1439281",
      "question_audio": null,
      "question_video": null,
      "map_id": 33067,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Decrease phenylalanine and Tyrosine in diet</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In case of <strong>Phenylketonuria</strong>, <strong>Tyrosine </strong>becomes a limiting amino acid and is <strong>increased in diet</strong> whereas <strong>phenylalanine </strong>is to be <strong>decreased.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Phenylketonuria</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">; Because of <strong>Phenylalanine Hydroxylase</strong> enzyme deficiency </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical Presentation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Infants are normal at birth</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mental retardation </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blond, blue eyed, with fair skin</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Eczema</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><strong><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Musty body odor of phenyacetic acid</span></span></span></strong></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vomiting is common and is often mistaken for pyloric stenosis</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Physical exam shows <strong>hyperactive deep tendon reflexes.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Decreased phenylalanine </strong>diet&nbsp; </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Early institution is essential to prevent the <strong>development of brain damage</strong></span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Increase tyrosine </strong>in diet.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Autosomal Recessive disorder: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PKU is indeed an autosomal recessive disorder, meaning that a <strong>child </strong>must inherit<strong> one defective gene </strong>from each <strong>parent</strong> to manifest the disease.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tendon reflexes in the baby are hyperreactive: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurological abnormalities, such as <strong>hyperactive reflexes</strong>, can occur in PKU due to the <strong>accumulation of phenylalanine</strong>, which can be<strong> toxic to the brain</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Most babies with PKU appear normal at birth: </span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Newborns </strong>with <strong>PKU </strong>typically appear <strong>normal at birth </strong>because <strong>maternal metabolism compensates for the enzyme deficiency during fetal development</strong>. <strong>Symptoms and signs </strong>develop later if the condition <strong>remains untreated</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Phenylketonuria (PKU)&nbsp;</strong>is a metabolic disorder characterized by a <strong>deficiency of the enzyme phenylalanine hydroxylase</strong>, which is necessary for converting <strong>phenylalanine to tyrosine</strong>. Dietary management of PKU involves <strong>reducing </strong>the <strong>intake of phenylalanine</strong>, which accumulates due to the enzyme deficiency. However, since<strong> tyrosine becomes an essential amino acid in individuals with PKU</strong>, it is necessary to <strong>ensure adequate tyrosine intake</strong>, not decrease it. Therefore, the correct dietary management should be to <strong>decrease phenylalanine and ensure sufficient tyrosine in the diet</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Nelson 21<sup>st</sup> edition, Chapter 103 &ndash; Page No 3131</span></strong></span></span></p>",
      "correct_choice_id": 65814,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16462,
      "choices": [
        {
          "id": 65808,
          "text": "<p><span style=\"font-size:12pt;\">Gauchers disease</span></p>"
        },
        {
          "id": 65809,
          "text": "<p><span style=\"font-size:12pt;\">Hurler’s disease</span></p>"
        },
        {
          "id": 65810,
          "text": "<p><span style=\"font-size:12pt;\">Hunters’ disease</span></p>"
        },
        {
          "id": 65811,
          "text": "<p><span style=\"font-size:12pt;\">Fabry’s disease</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 9-month-old child presents with recurrent infections, fatigue, and bleeding episodes. The attending physician notes anemia, leukopenia, and thrombocytopenia on a complete blood count. Upon examination, the child exhibits features suggestive of Mucopolysaccharidoses. Considering the clinical presentation and laboratory findings, the physician considers diseases for which enzyme replacement therapy (ERT) is not enough to treat the condition as a single aid. Which of the following diseases cannot be treated with enzyme replacement therapy alone?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture4.jpg\" alt=\"\" width=\"300\" height=\"332\"></span></p>",
      "unique_key": "Q3177408",
      "question_audio": null,
      "question_video": null,
      "map_id": 33066,
      "difficulty_level": "difficult",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. C) Hunter’s disease</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option C:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"background-color:white;color:#0d0d0d;font-size:16px;\"><strong>Hunter’s disease (Mucopolysaccharidosis type II) </strong>cannot be effectively managed with enzyme replacement therapy (ERT) alone. This limitation arises because the currently available enzyme formulations do not cross the blood-brain barrier, rendering them insufficient for addressing the neurological aspects of the disease. This necessitates additional therapeutic approaches for comprehensive management.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">All of the mucopolysaccharidoses are <strong>Autosomal Recessive</strong> in nature, whereas Hunters disease has <strong>X-Linked Recessive</strong> with a CAG trinucleotide repeat, CORNEAL CLOUDING IS NOT SEEN IN HUNTER DISEASE</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Common Presentations of Mucopolysaccharidoses:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mental retardation</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Developmental delay</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Severe behavioral problems</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Corneal clouding</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Coarse facial features</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Short stature, short trunk</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Skeletal irregularities</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hepatosplenomegaly</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cardiac disease</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Retinal degeneration</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hair loss or Hirsutism</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Coarse facial features (flat nasal bridge, thick lips and large tongue, Prominent forehead)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A. Gaucher's disease:&nbsp;</strong>Gaucher's disease is<strong> treatable </strong>with <strong>enzyme replacement therapy</strong> using <strong>imiglucerase, velaglucerase alfa, or taliglucerase alfa</strong>, which are recombinant forms of the deficient enzyme glucocerebrosidase.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.&nbsp;Hurler’s disease:&nbsp;</strong></span><span style=\"background-color:white;color:#0d0d0d;font-size:16px;\">Although Hurler's disease also requires more than ERT due to its severe and systemic nature, if addressing specifically enzyme replacement efficacy, it can still be part of the treatment protocol alongside other interventions like hematopoietic stem cell transplantation.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option D. Fabry’s disease:&nbsp;Fabry’s disease </strong>can be <strong>treated </strong>with enzyme replacement therapy using <strong>agalsidase beta or agalsidase alfa</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p><span style=\"background-color:white;color:#0d0d0d;font-size:16px;\">Hunter's disease, a form of Mucopolysaccharidosis, requires treatment approaches beyond enzyme replacement therapy due to its neurological involvement, which ERT alone cannot address.</span></p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Enzyme replacement therapy </strong>is available for <strong>Gauchers disease, Hurler’s disease, Fabry’s disease and Pompes disease</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref: </u>Nelson 21<sup>st</sup> edition, Chapter 107 – Page No 3551</strong></span></p>",
      "correct_choice_id": 65810,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16486,
      "choices": [
        {
          "id": 65904,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Recurrent infection</span></span></span></p>"
        },
        {
          "id": 65905,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver failure</span></span></span></p>"
        },
        {
          "id": 65906,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiorespiratory failure</span></span></span></p>"
        },
        {
          "id": 65907,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory failure</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 3-month-old infant is brought to the pediatric clinic by their mother, who is concerned about the child&#39;s apparent weakness and poor muscle tone. The mother also reports difficulty with feeding and the child&#39;s failure to gain weight appropriately. Physical examination reveals respiratory distress, hepatosplenomegaly, and an enlarged cardiac silhouette on chest X-ray. Given these findings and a suspicion of Glycogen Storage Disease (GSD), what is the most common cause of death in patients with this presentation?</span></span></span></p>",
      "unique_key": "Q2059013",
      "question_audio": null,
      "question_video": null,
      "map_id": 33065,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Cardiorespiratory failure</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical features mentioned in this case is suggestive of <strong>Pompes disease/type II GSD</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Its is due to the deficiency of <strong>acid alpha-glucosidase (acid maltase)</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical features include;</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Muscle weakness/hyptonia</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Feeding difficulty</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiomegaly</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory difficulty</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver and spleen enlargement.</span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/02/picture16_J8oCkk0.jpg\" style=\"height:235px; width:400px\" /></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Treatment</strong>: Enzyme replacement therapy.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Death</strong>- within 2 years by cardiorespiratory failure or respiratory infection by 1year.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Recurrent infection:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While <strong>infections </strong>can be a concern, especially in <strong>immunocompromised patients</strong>, they are <strong>not </strong>the <strong>primary cause of death in patients </strong>with the type of GSD described in the scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Liver failure:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liver involvement is common in several types of GSD, but <strong>liver failure </strong>is <strong>not </strong>the <strong>primary cause of death in Pompe disease</strong>, where <strong>cardiac and respiratory involvement </strong>is more <strong>significant</strong>.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Respiratory failure:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although <strong>respiratory failure </strong>is a <strong>critical component</strong>, it usually <strong>occurs in conjunction with cardiac failure in Pompe disease</strong>, making cardiorespiratory failure (C) a more comprehensive answer.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></u></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Pompe disease </strong>(Glycogen Storage Disease Type II), characterized by <strong>lysosomal alpha-1, 4-glucosidase </strong>(acid maltase) <strong>deficiency</strong>. This leads to <strong>glycogen accumulation in lysosomes</strong>, particularly affecting <strong>cardiac and skeletal muscles</strong>. The <strong>early infantile form </strong>presents with <strong>hypotonia, cardiomegaly, hepatomegaly</strong>, and <strong>respiratory distress</strong>. The most common cause of <strong>death in these patients </strong>is <strong>cardiorespiratory failure </strong>due to <strong>progressive hypertrophic cardiomyopathy </strong>and <strong>respiratory muscle weakness.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><u><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: </span></u></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelson 21<sup>st</sup> edition, Chapter 105 &ndash; Page No 3441-3446</span></strong></span></span></p>",
      "correct_choice_id": 65906,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16472,
      "choices": [
        {
          "id": 65848,
          "text": "<p><span style=\"font-size:12pt;\">X-Linked Dominant</span></p>"
        },
        {
          "id": 65849,
          "text": "<p><span style=\"font-size:12pt;\">X-Linked Recessive</span></p>"
        },
        {
          "id": 65850,
          "text": "<p><span style=\"font-size:12pt;\">Autosomal Recessive</span></p>"
        },
        {
          "id": 65851,
          "text": "<p><span style=\"font-size:12pt;\">Autosomal Dominant</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 5-year-old child with mucopolysaccharidoses (MPS) presents for regular follow-up. Upon evaluation, severe pallor, signs of easy bruisability, coarse facies, and clear cornea are noted. Suspecting Hunter's disease, what is the pattern of inheritance for this condition?</span></p>",
      "unique_key": "Q3953521",
      "question_audio": null,
      "question_video": null,
      "map_id": 33064,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) X-Linked Recessive</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">All of the mucopolysaccharidoses are <strong>Autosomal Recessive</strong> in nature, whereas Hunters disease has <strong>X-Linked Recessive</strong> it also has <strong>clear cornea</strong>.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Common Presentations</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Mental retardation</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Developmental delay</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Severe behavioral problems</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Coarse facial features</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Short stature, short trunk</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Skeletal irregularities</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hepatosplenomegaly</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Cardiac disease</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Retinal degeneration</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hair loss or Hirsuitism</span></p></li><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Coarse facial features (flat nasal bridge, thick lips and large tongue, Prominent forehead)</span></p></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Explanation:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A, C and D </strong>are not appropriate as Hunters disease is a <strong>X-Linked Recessive disease.</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Educational Objective:</u></strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Hunter syndrome</strong>, also known as <strong>mucopolysaccharidosis type II (MPS II),&nbsp; </strong>is an <strong>X-linked recessive disorder </strong>caused by a <strong>deficiency of the enzyme iduronate sulfatase (IDS).&nbsp;</strong>This deficiency leads to the <strong>accumulation of glycosaminoglycans (GAGs)&nbsp;</strong>in various tissues.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Hunter syndrome is <strong>X-linked recessive</strong>, it primarily<strong> affects males</strong>, while <strong>females may be carriers </strong>of the condition.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong><u>Ref: </u>Nelson 21<sup>st</sup> Edition, Chapter 107 – Page No 3551</strong></span></p>",
      "correct_choice_id": 65849,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}